Alpana Mair

Alpana Mair

Alpana Mair

Lecturer

Esteem

Advisory panels and expert committees or witness

  • Polypharmacy Guidance : Royal Pharmaceutical Society of Great Britain
  • WHO Global Patient Safety Challenge: Medication Without Harm
  • WHO Patient Safety Flagship
  • Prescribing Competencies : Royal Pharmaceutical Society Great Britain
  • DG Sante EU Innovation Partnership Polypharmacy and Adherence Lead
  • Board Member Royal Pharmaceutical Society of Great Britain

 

Conference Activity

  • International Foundation of Integrated Care, Scientific Committee
  • ESPACOMP Scientific committee

 

Editorial Activity

  • Journal of Patient Safety and Risk Management

 

Fellowships and Awards

  • Faculty Fellow Royal Pharmaceutical Society of Great Britain

 

Invited Speaker

  • Person Centred Approach to Address Medication Use : DigiHealth Conference
  • SIMPATHY and iSIMPATHY Intereg France :Spain_Optimage
  • Implementing the WHO Third Global Patient Challenge: Flagship Reports
  • Implementing The WHO challange in Scotland: Policy to Practice
  • Pharmacotherapy management systems in Scotland: University of Seville
  • Vaccination Safety: International Federation of Pharmacists
  • Patient Safety : Improving polypharmacy across Europe: International Federation of Pharmacists
  • Addressing Polypharmacy by targeting High Risk medicines : International Society of Pharmacovigilance
  • Polypharmacy and age related Disease: Croatian Government
  • Implementing Polypharmacy and Adherence programmes : IFIC
  • Digital solutions to address person centred medicines use: Ageing Fit, Nice
  • Findings from SIMPATHY and moving to iSIMPATHY
  • Health and ageing in the XXI century: University Egas Moniz, Portugal
  • WHO Flagship reports to Address Medication without Harm
  • Pharmacovigilance, prescribing in the Elderly and Polypharmacy , WHO Asia Pacific
  • Adherence and Ageing: Royal College of Physicians Edinburgh
  • Findings from SIMPATHY: ESPACOMP conference
  • Findings from SIMPATHY: European Geriatric Medicines Society
  • Scottish Polypharmacy Guidance : UK Medicines Information
  • Patient Safety and Appropriate Polypharmacy; International Federation of Pharmacists
  • Drug Development and Appropriate Polypharmacy; International Federation of Pharmacists
  • Scottish Polypharmacy guidance and SIMPATHY
  • Integrated Care and Polypharmacy Management
  • Not another pill : Institute of Healthcare Improvement
  • Outcomes of the A1 Action Group: Conference of Partners
  • Management of Polypharmacy at Scale
  • WHO Global Medication Safety Challenge; WHO Uppsala and WHO Asia Pacific
  • Polypharmacy and Pharmacovigilance: WHO Uppsala Monitoring Centre
  • Implementing SIMPATHY findings in Portugal
  • Polypharmacy as a FlagShip project: WHO Eastern Mediterranean Ministerial Launch
  • WHO Ministerial Launch of Global Patient Safety Challenge: Medication without Harm
  • Aging Pharmacists Role: International Federation of Pharmacists
  • Polypharmacy and pharmacists role: International Federation Pharmacist
  • SIMPATHY implementation ; European Clinical Pharmacists Society
  • Sustainable Implementation Of Polypharmacy Reviews : IFIC
  • A1 Action Group achievements: SIMPATHY, EC Conference of Partners

 

Membership of Professional Body

  • Royal Pharmaceutical Society of Great Britain

 

Public/Community Engagement

  • iSIMPATHY ministerial Launch
  • SIMPATHY Ministerial Launch

 

Reviewing

  • International Journal of Integrated Care
  • Journal of Patient Safety and Risk Management
  • Journal of Patient Safety

 

Visiting Positions

  • Robert Gordon
  • University of Strathclyde

 

Date


35 results

Polypharmacy and Integrated Care

Book Chapter
Mair, A. (in press)
Polypharmacy and Integrated Care. In V. Amelung, V. Stein, E. Suter, N. Goodwin, E. Nolte, & R. Balicer (Eds.), Handbook Integrated Care. Cham: Springer. https://doi.org/10.1007/978-3-030-69262-9

Appropriate polypharmacy: a barometer for integrated care

Journal Article
Mair, A., Antoniadou, E., Hendry, A., & Gabrovec, B. (2021)
Appropriate polypharmacy: a barometer for integrated care. Journal of Integrated Care, 29(2), 204-214. https://doi.org/10.1108/jica-04-2020-0019
Purpose Polypharmacy, the concurrent use of multiple medicines by one individual, is a common and growing challenge driven by an ageing population and the growing number of pe...

Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

Journal Article
Pazan, F., Petrovic, M., Cherubini, A., Onder, G., Cruz-Jentoft, A. J., Denkinger, M., …Wehling, M. (2021)
Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials. European Journal of Clinical Pharmacology, 77(1), 1-12. https://doi.org/10.1007/s00228-020-02951-8
Background Frailty and adverse drug effects are linked in the fact that polypharmacy is correlated with the severity of frailty; however, a causal relation has not been proven...

Addressing the Challenge of Polypharmacy

Journal Article
Mair, A., Wilson, M., & Dreischulte, T. (2020)
Addressing the Challenge of Polypharmacy. Annual Review of Pharmacology and Toxicology, 60(1), 661-681. https://doi.org/10.1146/annurev-pharmtox-010919-023508
Polypharmacy describes the concomitant use of multiple medicines and represents a growing global challenge attributable to aging populations with an increasing prevalence of m...

Quality Prescribing for Chronic Pain: A Guide for Improvement

Report
Chronic Pain Expert group, , & Scottish Government, . (2019)
Quality Prescribing for Chronic Pain: A Guide for Improvement. Edinburgh: Scottish Government

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

Journal Article
Bousquet, J. J., the ARIA Study Group, , Schünemann, H. J., Togias, A., Erhola, M., Hellings, P. W., …the MASK Study Group, . (2019)
Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clinical and Translational Allergy, 9, https://doi.org/10.1186/s13601-019-0279-2
Background In all societies, the burden and cost of allergic and chronic respiratory diseases are increasing rapidly. Most economies are struggling to deliver modern health ca...

The polypharmacy programme in Scotland: realistic prescribing

Journal Article
Mair, A., Wilson, M., & Dreischulte, T. (2019)
The polypharmacy programme in Scotland: realistic prescribing. Prescriber, 30(8), 10-16. https://doi.org/10.1002/psb.1779
Since 2012, NHS Scotland has published a series of polypharmacy guidelines to help clinicians address the many medication‐related problems arising from multimorbidity. Here, A...

Medication safety in polypharmacy: technical report

Report
Mair, A. (2019)
Medication safety in polypharmacy: technical report. Geneva: WHO
As the population ages more people are likely to suffer from multiple long term illness and take multiple medications. It is essential to therefore take a person-centred appro...

Medication Safety in Transitions of Care: Technical Report

Report
World Health Organisation, . (2019)
Medication Safety in Transitions of Care: Technical Report. Geneva: WHO
Medication discrepancies impact almost every patient that moves across transitions of care, e.g. admission to or discharge from hospital. WHO urges countries to prioritise ear...

Medication Safety in High Risk Situations

Report
World Health Organization, . (2019)
Medication Safety in High Risk Situations. Geneva: World Health Organization

Pre-Napier Funded Projects

  • iSIMPATHY
  • Pharmacist Street Outreach for Homeless people
  • SIMPATHY

Current Post Grad projects

Non-Napier PhD or MSc by Research supervisions

  • Polypharmacy
  • Impact of a National Formulary